Literature DB >> 31933914

Human papillomavirus genotypes and p16 expression in oral leukoplakia and squamous cell carcinoma.

Li-Qun Yang1,2,3,4, Xuan Xiao5, Chen-Xi Li1,2, Wen-Yan Wu1,2, Xue-Min Shen1,2, Zeng-Tong Zhou1,2, Yuan Fan3,4, Lin-Jun Shi1,2.   

Abstract

Several studies have shown a broad variation in the prevalence of human papillomavirus (HPV) in oral leukoplakia (OLK) and oral squamous cell carcinoma (OSCC), whereas the relationship is less well-defined and specific HPV genotypes lack examination in OLK. In the present study, the role of HPV and surrogate p16 expression was investigated to explore the correlation and pathogenesis in OLK and OSCC. Polymerase chain reaction (PCR) and flow-through hybridization technology were utilized to detect HPV genotypes in oral exfoliated cells from 30 healthy volunteers, 103 OLK and 30 OSCC patients. Expression of p16 was assessed by immunohistochemistry (IHC) in biopsies from these OLK and OSCC, in addition to 15 normal oral mucosal tissues as the control group. The healthy controls showed 3.3% (1/30) HPV presence; In OLK and OSCC, the detection rate was 4.9% (5/103), 3.3% (1/30), respectively. No significant relationship between HPV and OLK or OSCC was observed when compared with the control group (P>0.05). All 6 HPV-positive OLK and OSCC cases had p16 overexpression. But the sensitivity of p16 IHC was poor, because 88.4% (38/43) of p16 over-expressed OLK were HPV negative. There was no statistical significance between HPV and the sex, age, site, alcohol consumption, or smoking. These findings suggested HPV had a low prevalence in OLK and OSCC. This suggests the detection of HPV genotypes by PCR in exfoliated cells combined with p16 IHC may be more accurate to represent HPV infection. IJCEP
Copyright © 2019.

Entities:  

Keywords:  Oral leukoplakia; human papillomavirus; oral squamous cell carcinoma; p16

Year:  2019        PMID: 31933914      PMCID: PMC6945145     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  33 in total

1.  High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.

Authors:  Odey C Ukpo; John J Flanagan; Xiao-Jun Ma; Yuling Luo; Wade L Thorstad; James S Lewis
Journal:  Am J Surg Pathol       Date:  2011-09       Impact factor: 6.394

2.  High-risk human papillomavirus load and biomarkers in cervical intraepithelial neoplasia and cancer.

Authors:  Mee Soo Chang; Sohee Oh; Eun-Jung Jung; Jeong Hwan Park; Hye-Won Jeon; Taek Sang Lee; Jung Ho Kim; Euno Choi; Sun-Ju Byeon; In-Ae Park
Journal:  APMIS       Date:  2013-09-11       Impact factor: 3.205

3.  Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status.

Authors:  James S Lewis; Rebecca D Chernock; Xiao-Jun Ma; John J Flanagan; Yuling Luo; Ge Gao; Xiaowei Wang; Samir K El-Mofty
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

Review 4.  Malignant transformation of oral leukoplakia: a systematic review of observational studies.

Authors:  S Warnakulasuriya; A Ariyawardana
Journal:  J Oral Pathol Med       Date:  2015-07-20       Impact factor: 4.253

5.  Low prevalence of high risk genotypes of human papilloma virus in normal oral mucosa, oral leukoplakia and verrucous carcinoma.

Authors:  Nasrollah Saghravanian; Kiarash Ghazvini; Shahab Babakoohi; Alireza Firooz; Nooshin Mohtasham
Journal:  Acta Odontol Scand       Date:  2011-04-05       Impact factor: 2.331

6.  Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.

Authors:  J Laco; J Nekvindova; V Novakova; P Celakovsky; H Dolezalova; L Tucek; H Vosmikova; M Vosmik; T Neskudlova; E Cermakova; M Hacova; F A Sobande; A Ryska
Journal:  Neoplasma       Date:  2012       Impact factor: 2.575

7.  Comparison of the prevalence of human papilloma virus infection in histopathologically confirmed premalignant oral lesions and healthy oral mucosa by brush smear detection.

Authors:  Daniel Dalla Torre; Doris Burtscher; Michael Edlinger; Elisabeth Sölder; Andreas Widschwendter; Michael Rasse; Wolfgang Puelacher
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2014-12-05

8.  Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.

Authors:  Mark W Lingen; Weihong Xiao; Alessandra Schmitt; Bo Jiang; Robert Pickard; Paul Kreinbrink; Bayardo Perez-Ordonez; Richard C Jordan; Maura L Gillison
Journal:  Oral Oncol       Date:  2012-07-28       Impact factor: 5.337

9.  Human papillomavirus in oral leukoplakia is no prognostic indicator of malignant transformation.

Authors:  Shih-Wei Yang; Yun-Shien Lee; Tai-An Chen; Chang-Jer Wu; Chi-Neu Tsai
Journal:  Cancer Epidemiol       Date:  2009-06-07       Impact factor: 2.984

Review 10.  The human papillomavirus family and its role in carcinogenesis.

Authors:  Massimo Tommasino
Journal:  Semin Cancer Biol       Date:  2013-12-04       Impact factor: 15.707

View more
  3 in total

1.  Presence of Human Papillomavirus and Epstein-Barr Virus, but Absence of Merkel Cell Polyomavirus, in Head and Neck Cancer of Non-Smokers and Non-Drinkers.

Authors:  Frans J Mulder; Faisal Klufah; Famke M E Janssen; Farzaneh Farshadpour; Stefan M Willems; Remco de Bree; Axel Zur Hausen; Mari F C M van den Hout; Bernd Kremer; Ernst-Jan M Speel
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244

2.  Human papillomavirus and leukoplakia of the oral cavity: a systematic review.

Authors:  Dominik Radzki; Aida Kusiak; Iwona Ordyniec-Kwaśnica; Arleta Bondarczuk
Journal:  Postepy Dermatol Alergol       Date:  2021-09-20       Impact factor: 1.664

3.  Human papillomavirus, Epstein-Barr virus, and Candida albicans co-infection in oral leukoplakia with different degrees of dysplasia.

Authors:  Alveiro T Erira; Andrea Fernanda Romo Navarro; Dabeiba Adriana García Robayo
Journal:  Clin Exp Dent Res       Date:  2021-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.